Screener
Amneal Pharmaceuticals, Inc. AMRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $5.53B.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s market capitalization?
- Amneal Pharmaceuticals, Inc. (AMRX) reported market capitalization of $5.53B in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s market capitalization increased by 116.9% year-over-year, from $2.55B to $5.53B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s market capitalization has grown at a 42.1% compound annual growth rate (CAGR), from $682.63M to $3.96B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Amneal Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude